Biofidelity raised €22M in a funding round in Apr 2024. The company is based in Cambridge, UK. Investors in the round: Agilent Technologies, Blueyard Capital, Longwall Ventures and 1 other. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
